Latest News for Agile Therapeutics Stock (NASDAQ:AGRX)

Wednesday, December 06, 2023

Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market
Benzinga Newsdesk - 1 day ago

Tuesday, November 21, 2023

Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
Meg Flippin - Sponsored

Thursday, November 09, 2023

Agile Therapeutics Reaffirms Expected Full Year 2023 Net Revenue of At Least $25M Versus Consensus Of $23.40M
Benzinga Newsdesk - Nov 9, 2023, 8:12AM
Agile Therapeutics' Twirla Delivered $6.7M In Q3 Net Revenue, Up 122% Y/Y
Benzinga Newsdesk - Nov 9, 2023, 8:11AM
Agile Therapeutics Q3 Adjusted EPS $(1.47) Beats $(1.84) Estimate, Sales $6.66M Beat $5.27M Estimate
Benzinga Newsdesk - Nov 9, 2023, 8:10AM
Earnings Scheduled For November 9, 2023
Benzinga Insights - Nov 9, 2023, 6:52AM

Monday, October 16, 2023

A Look Into Healthcare Sector Value Stocks
Benzinga Insights - Oct 16, 2023, 10:44AM

Wednesday, September 27, 2023

Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group
Johnny Rice - Sponsored

Monday, September 25, 2023

5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights - Sep 25, 2023, 10:44AM

Friday, September 22, 2023

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Benzinga Insights - Sep 22, 2023, 11:00AM
Maxim Group Upgrades Agile Therapeutics to Buy, Announces $5 Price Target
Benzinga Newsdesk - Sep 22, 2023, 9:32AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Sep 22, 2023, 9:06AM

Thursday, September 21, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Sep 21, 2023, 12:08PM

Tuesday, September 19, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Sep 19, 2023, 12:50PM

Thursday, August 17, 2023

Agile Says It's On Track To Hit $25M-$30M Net Annual Revenue After A Strong Performance In Q2
Happy Mohamed - Aug 17, 2023, 9:16AM

Wednesday, August 16, 2023

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
Rachael Green - Sponsored

Monday, August 14, 2023

A Look Into Healthcare Sector Value Stocks
Benzinga Insights - Aug 14, 2023, 10:44AM

Wednesday, August 09, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM
UPDATE: Agile Therapeutics Q2 Adj $(3.10) Beats $(3.48) Estimate, Sales $5.50M Beat $4.68M Estimate
Benzinga Newsdesk - Aug 9, 2023, 8:32AM
Agile Therapeutics Q2 Adj $(3.10) Beats $(3.48) Estimate, Sales $5.50M Beat $4.68M Estimate
Benzinga Newsdesk - Aug 9, 2023, 8:09AM
Earnings Scheduled For August 9, 2023
Benzinga Insights - Aug 9, 2023, 4:54AM

Tuesday, July 18, 2023

Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
Happy Mohamed - Jul 18, 2023, 9:04AM

Monday, July 17, 2023

This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions Of Women Thanks To A Partnership With Afaxys
Rachael Green - Sponsored

Friday, July 14, 2023

Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
Rachael Green - Sponsored

Monday, July 10, 2023

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage
Rachael Green - Sponsored

Monday, July 03, 2023

Why Tattooed Chef Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 3, 2023, 8:15AM

Thursday, June 29, 2023

H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
Rachael Green - Sponsored

Tuesday, June 27, 2023

Agile Therapeutics Appoints Scott Coiante To Serve As Senior Vice President, CFO And Treasurer, Effective August 16
Benzinga Newsdesk - Jun 27, 2023, 4:50PM

Monday, June 26, 2023

This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023
Rachael Green - Sponsored
Agile Therapeutics Announces The Availability Of Twirla To MMCAP Infuse Members Effective July 1
Benzinga Newsdesk - Jun 26, 2023, 8:05AM
HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target
Benzinga Newsdesk - Jun 26, 2023, 6:11AM

Friday, June 16, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Jun 16, 2023, 1:08PM
Agile Therapeutics – This Women's Healthcare Company's "Skinfusion" Technology Sets It Apart From Other Contraceptive Companies
Johnny Rice - Jun 16, 2023, 8:03AM

Thursday, June 15, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Jun 15, 2023, 2:53PM

Wednesday, June 14, 2023

Why Agile Therapeutics Stock Is Trading Higher Today
Vandana Singh - Jun 14, 2023, 9:29AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Jun 14, 2023, 9:07AM
Agile Therapeutics shares are trading higher after the company announced an agreement with VitaCare to improve access to Twirla, expand commercial reach
Benzinga Newsdesk - Jun 14, 2023, 8:23AM
Late Tuesday, Agile Therapeutics Announced An Agreement With Vitacare Prescription Services To Improve Access To Twirla, Expanding Commercial Reach
Benzinga Newsdesk - Jun 14, 2023, 8:20AM
Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 14, 2023, 8:07AM

Tuesday, June 13, 2023

Agile Therapeutics Announces New Agreement With VitaCare Prescription Services To Improve Access To Twirla; Expanding Commercial Reach Through Partnerships Continues To Drive Company's Belief In Achieving 2023 Net Revenue In The Range Of $25M-$30M
Benzinga Newsdesk - Jun 13, 2023, 4:08PM

Monday, June 12, 2023

5 Value Stocks In The Healthcare Sector
Benzinga Insights - Jun 12, 2023, 10:44AM

Wednesday, June 07, 2023

HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target
Benzinga Newsdesk - Jun 7, 2023, 7:00AM

Monday, June 05, 2023

Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 – What Is The Hype All About?
Faith Ashmore - Sponsored

Thursday, June 01, 2023

The Overturning of Roe v. Wade Has Changed The Landscape Of Birth Control; Smaller Companies Are Now An Integral Part Of Care
Faith Ashmore - Sponsored

Tuesday, May 23, 2023

Agile Therapeutics Has Priced Its Public Offering Of 1.89M, Together With Accompanying Common Stock Warrants, At $3.9551 Per Share (Or Pre-funded Warrant) And Accompanying Warrants, For A Gross Proceed Of Approximately $7.5M
Benzinga Newsdesk - May 23, 2023, 4:09AM

Monday, May 22, 2023

A Look Into Healthcare Sector Value Stocks
Benzinga Insights - May 22, 2023, 10:43AM

Tuesday, May 16, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - May 16, 2023, 1:01PM

Thursday, May 11, 2023

Agile Therapeutics: Q1 Earnings Insights
Benzinga Insights - May 11, 2023, 4:20PM
Agile Therapeutics Q1 Adj EPS $(7.76) Misses $(7.50) Estimate, Sales $3.81M Beat $3.40M Estimate
Benzinga Newsdesk - May 11, 2023, 4:17PM
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - May 11, 2023, 1:47PM

Open2.320	Close2.350
Vol / Avg.35.722K / 43.471K	Mkt Cap5.676M
Day Range2.250 - 2.399	52 Wk Range1.650 - 16.000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Agile Therapeutics Stock (NASDAQ:AGRX)

Wednesday, December 06, 2023

Tuesday, November 21, 2023

Thursday, November 09, 2023

Monday, October 16, 2023

Wednesday, September 27, 2023

Monday, September 25, 2023

Friday, September 22, 2023

Thursday, September 21, 2023

Tuesday, September 19, 2023

Thursday, August 17, 2023

Wednesday, August 16, 2023

Monday, August 14, 2023

Wednesday, August 09, 2023

Tuesday, July 18, 2023

Monday, July 17, 2023

Friday, July 14, 2023

Monday, July 10, 2023

Monday, July 03, 2023

Thursday, June 29, 2023

Tuesday, June 27, 2023

Monday, June 26, 2023

Friday, June 16, 2023

Thursday, June 15, 2023

Wednesday, June 14, 2023

Tuesday, June 13, 2023

Monday, June 12, 2023

Wednesday, June 07, 2023

Monday, June 05, 2023

Thursday, June 01, 2023

Tuesday, May 23, 2023

Monday, May 22, 2023

Tuesday, May 16, 2023

Thursday, May 11, 2023